Drugmakers AstraZeneca and Johnson & Johnson both said Friday they are set to resume their paused coronavirus vaccine trials in the United States after health scares.
AstraZeneca's trial had been on hold since early September, and Johnson & Johnson's trial had been paused since earlier this month
"Preparations to resume the trial in the United States are now underway,"
Popular News Stories
Related News
Coronavirus vaccine update: US trial of AstraZeneca COVID vaccine may resume this week
AstraZeneca COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a...
International Business Times 2020-10-21AstraZeneca, J&J resuming US tests of COVID-19 vaccines
Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates. Testing of AstraZeneca’s vaccine candidate had been halted since early...

Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources
AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its...
The Times of India 2020-10-21U.S. trial of AstraZeneca COVID-19 vaccine may resume this week, sources say
CHICAGO/WASHINGTON, Oct. 20 (Reuters) — AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and...
Grand Forks Herald 2020-10-21U.S. trial of AstraZeneca COVID-19 vaccine may resume this week sources tell Reuters
CHICAGO/WASHINGTON, Oct 20 (Reuters) - AstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and...
Post Bulletin 2020-10-21Exclusive: U.S. trial of AstraZeneca COVID-19 vaccine may resume this week – sources
Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York City CHICAGO/WASHINGTON (Reuters) – AstraZeneca Plc’s
Coronavirus vaccine volunteer in Brazil's AstraZeneca trial dies -- but authorities say trial to continue
A volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died, the Brazilian health agency Anvisa announced on Wednesday, but organizers said...
